AAAAAA

   
Results: 1-11 |
Results: 11

Authors: KAMPFER S HELLBERT K VILLUNGER A DOPPLER W BAIER G GRUNICKE HH UBERALL F
Citation: S. Kampfer et al., TRANSCRIPTIONAL ACTIVATION OF C-FOS BY ONCOGENIC HA-RAS IN MOUSE MAMMARY EPITHELIAL-CELLS REQUIRES THE COMBINED ACTIVITIES OF PKC-LAMBDA, PKC-EPSILON AND PKC-ZETA, EMBO journal (Print), 17(14), 1998, pp. 4046-4055

Authors: VILLUNGER A EGLE A KOS M EGLE D TINHOFER I HENN T UBERALL F MALY K GREIL R
Citation: A. Villunger et al., FUNCTIONAL GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR IS CONSTITUTIVELY EXPRESSED ON NEOPLASTIC PLASMA-CELLS AND MEDIATES TUMOR-CELL LONGEVITY/, British Journal of Haematology, 102(4), 1998, pp. 1069-1080

Authors: TINHOFER I MARSCHITZ I KOS M HENN T EGLE A VILLUNGER A GREIL R
Citation: I. Tinhofer et al., DIFFERENTIAL SENSITIVITY OF CD4(-LYMPHOCYTES TO THE KILLING EFFICACY OF FAS (APO-1() AND CD8(+) T)CD95) LIGAND(+) TUMOR-CELLS IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA/, Blood, 91(11), 1998, pp. 4273-4281

Authors: GELEY S HARTMANN BL KAPELARI K EGLE A VILLUNGER A HEIDACHER D GREIL R AUER B KOFLER R
Citation: S. Geley et al., THE INTERLEUKIN 1-BETA-CONVERTING ENZYME-INHIBITOR CRMA PREVENTS APO1FAS-INDUCED BUT NOT GLUCOCORTICOID-INDUCED POLY(ADP-RIBOSE) POLYMERASE CLEAVAGE AND APOPTOSIS IN LYMPHOBLASTIC-LEUKEMIA CELLS/, FEBS letters, 402(1), 1997, pp. 36-40

Authors: VILLUNGER A EGLE A KOS M HARTMANN BL GELEY S KOFLER R GREIL R
Citation: A. Villunger et al., DRUG-INDUCED APOPTOSIS IS ASSOCIATED WITH ENHANCED FAS (APO-1 CD95) LIGAND EXPRESSION BUT OCCURS INDEPENDENTLY OF FAS (APO-1/CD95) SIGNALING IN HUMAN T-ACUTE LYMPHATIC-LEUKEMIA CELLS/, Cancer research, 57(16), 1997, pp. 3331-3334

Authors: EGLE A VILLUNGER A MARSCHITZ I KOS M HITTMAIR A LUKAS P GRUNEWALD K GREIL R
Citation: A. Egle et al., EXPRESSION OF APO-1 FAS (CD95), BCL-2, BAX AND BCL-X IN MYELOMA CELL-LINES - RELATIONSHIP BETWEEN RESPONSIVENESS TO ANTI-FAS MAB AND P53 FUNCTIONAL STATUS/, British Journal of Haematology, 97(2), 1997, pp. 418-428

Authors: GREIL R VILLUNGER A EGLE A MARSCHITZ L KOS M BOCK G LUDWIG H GELEY S KOFLER R
Citation: R. Greil et al., FAS (APO-1 CD95) - LIGAND EXPRESSION ON NEOPLASTIC PLASMA-CELLS AND ITS ROLE FOR THE EXPANSION OF THE NEOPLASTIC CLONE/, Blood, 90(10), 1997, pp. 1578-1578

Authors: VILLUNGER A EGLE A MARSCHITZ I KOS M BOCK G LUDWIG H GELEY S KOFLER R GREIL R
Citation: A. Villunger et al., CONSTITUTIVE EXPRESSION OF FAS (APO-1 CD95) LIGAND ON MULTIPLE-MYELOMA CELLS - A POTENTIAL MECHANISM OF TUMOR-INDUCED SUPPRESSION OF IMMUNESURVEILLANCE/, Blood, 90(1), 1997, pp. 12-20

Authors: GRUBER J GEISEN F SGONC R EGLE A VILLUNGER A BOECK G KONWALINKA G GREIL R
Citation: J. Gruber et al., 2',2'-DIFLUORODEOXYCYTIDLINE (GEMCITABINE) INDUCES APOPTOSIS IN MYELOMA CELL-LINES RESISTANT TO STEROIDS AND 2-CHLORODEOXYADENOSINE (2-CDA), Stem cells, 14(3), 1996, pp. 351-362

Authors: VILLUNGER A EGLE A KOS M HITTMAIR A MALY K GREIL R
Citation: A. Villunger et al., CONSTITUENTS OF AUTOCRINE IL-6 LOOPS IN MYELOMA CELL-LINES AND THEIR TARGETING FOR SUPPRESSION OF NEOPLASTIC GROWTH BY ANTIBODY STRATEGIES, International journal of cancer, 65(4), 1996, pp. 498-505

Authors: EGLE A VILLUNGER A KOS M BOCK G GRUBER J AUER B GREIL R
Citation: A. Egle et al., MODULATION OF APO-1 FAS (CD95)-INDUCED PROGRAMMED CELL-DEATH IN MYELOMA CELLS BY INTERFERON-ALPHA(2)/, European Journal of Immunology, 26(12), 1996, pp. 3119-3126
Risultati: 1-11 |